PMID: 8610220Jan 1, 1995Paper

Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine

Scandinavian Journal of Rheumatology
J SörensenM Bengtsson

Abstract

Pain intensity, muscle strength, static muscle endurance, pressure pain threshold, and pain tolerance at tender points and control points were assessed in 31 patients with fibromyalgia (FM), before and after intravenous administration of morphine (9 patients), lidocaine (11 patients), and ketamine (11 patients). The three different studies were double-blind and placebo-controlled. The patients were classified as placebo-responders, responders (decrease in pain intensity by > 50%) and non-responders. The morphine test did not show any significant changes. The lidocaine test showed a pain decrease during and after the infusion. The ketamine test showed a significant reduction in pain intensity during and after the test period. Tenderness at tender points decreased and endurance increased significantly, while muscle strength remained unchanged. The present results support the hypothesis that the NMDA receptors are involved in pain mechanisms in fibromyalgia. These findings also suggest that central sensitization is present in FM and that tender points represent secondary hyperalgesia.

Associated Clinical Trials

References

Jan 1, 1989·Journal of Pineal Research·V SimonneauxH Vaudry
Sep 1, 1986·Neurological Research·P PetersenG Boysen
May 1, 1982·British Journal of Anaesthesia·R A BoasA Shahnarian
Jan 1, 1982·Medicine and Science in Sports and Exercise·G A Borg
Nov 1, 1994·Archives of Physical Medicine and Rehabilitation·M H LindhG L Grimby
Oct 9, 1993·Lancet·M L Cohen, J L Quintner

❮ Previous
Next ❯

Citations

Oct 8, 1999·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·S R Block
May 7, 2008·Der Schmerz·C SommerD O Nutzinger
Jul 5, 2012·Der Schmerz·C SommerUNKNOWN Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften
Mar 6, 2009·Clinical Rheumatology·Marcelo Derbli SchafranskiFabielle Harth
Jun 14, 2001·Current Pain and Headache Reports·A Barkhuizen
Nov 8, 2003·Current Pain and Headache Reports·Karl G Henriksson
Sep 27, 2007·Current Pain and Headache Reports·Paola SarchielliPaolo Calabresi
Nov 1, 2008·Current Pain and Headache Reports·Philip J Mease, Kristin Seymour
Aug 10, 1999·Journal of Pain and Symptom Management·K Fisher, N A Hagen
Mar 4, 2000·European Journal of Pain : EJP·E KalsoR A Moore
Jul 10, 2003·Best Practice & Research. Clinical Rheumatology·Srinivas G Rao, Robert M Bennett
Jul 16, 2005·Traffic Injury Prevention·Samuel A McLeanDaniel J Clauw
Feb 5, 1999·Acta Anaesthesiologica Scandinavica. Supplementum·S Arnér
Feb 10, 2011·International Journal of Rheumatic Diseases·Gene-Siew NgianGeoffrey O Littlejohn
Jun 10, 2006·Arthritis Research & Therapy·Lesley M Arnold
Sep 7, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·D van West, M Maes
Apr 14, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Eric GuedjOlivier Mundler
Sep 25, 2014·Current Pain and Headache Reports·Leonardo Ierardi GoulartMario Fernando Prieto Peres
Dec 21, 2000·Current Rheumatology Reports·J H ParkN Olsen
Sep 24, 2011·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Sheetal Patil, Magdalena Anitescu
Aug 10, 2007·Expert Opinion on Pharmacotherapy·Roland Staud
Oct 22, 2002·Expert Opinion on Investigational Drugs·Kim Lawson
May 16, 2007·Expert Opinion on Investigational Drugs·Patrick B WoodKim D Jones
Dec 23, 2015·Toxins·Nehan R Munasinghe, MacDonald J Christie
Jul 24, 2012·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Nicholas FallonAndrej Stancak
Mar 7, 2012·Medical Hypotheses·Dennis J McCarthyGerard Sanacora
Nov 19, 2011·Best Practice & Research. Clinical Rheumatology·Philip J MeasePiercarlo Sarzi-Puttini
Aug 4, 2009·Rheumatic Diseases Clinics of North America·Philip J Mease, Ernest H Choy
Jul 3, 2007·Best Practice & Research. Clinical Rheumatology·Lars Arendt Nielsen, Karl G Henriksson
Apr 27, 2007·Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology·Björn GerdleJ Stefan Karlsson
Mar 16, 2016·Mayo Clinic Proceedings·Don L GoldenbergAndrew G Clair
Nov 19, 2004·European Urology·M FallUNKNOWN European Association of Urology
Oct 7, 2006·The Journal of Pain : Official Journal of the American Pain Society·Patrick B WoodDavid L Lilien
Jul 21, 2006·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·E Visser, S A Schug

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.